JP2007526318A5 - - Google Patents

Download PDF

Info

Publication number
JP2007526318A5
JP2007526318A5 JP2007501899A JP2007501899A JP2007526318A5 JP 2007526318 A5 JP2007526318 A5 JP 2007526318A5 JP 2007501899 A JP2007501899 A JP 2007501899A JP 2007501899 A JP2007501899 A JP 2007501899A JP 2007526318 A5 JP2007526318 A5 JP 2007526318A5
Authority
JP
Japan
Prior art keywords
seq
amino acid
acid sequence
polypeptide
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2007501899A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007526318A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/006588 external-priority patent/WO2005084306A2/en
Publication of JP2007526318A publication Critical patent/JP2007526318A/ja
Publication of JP2007526318A5 publication Critical patent/JP2007526318A5/ja
Withdrawn legal-status Critical Current

Links

JP2007501899A 2004-03-02 2005-03-02 Chlamydiapneumoniaeに対する免疫原性組成物 Withdrawn JP2007526318A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US54983204P 2004-03-02 2004-03-02
US64311005P 2005-01-12 2005-01-12
US64455205P 2005-01-19 2005-01-19
PCT/US2005/006588 WO2005084306A2 (en) 2004-03-02 2005-03-02 Immunogenic compositions for chlamydia pneunomiae

Publications (2)

Publication Number Publication Date
JP2007526318A JP2007526318A (ja) 2007-09-13
JP2007526318A5 true JP2007526318A5 (https=) 2008-04-03

Family

ID=34923269

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007501899A Withdrawn JP2007526318A (ja) 2004-03-02 2005-03-02 Chlamydiapneumoniaeに対する免疫原性組成物

Country Status (6)

Country Link
EP (1) EP1729800A4 (https=)
JP (1) JP2007526318A (https=)
BR (1) BRPI0508365A (https=)
CA (1) CA2557353A1 (https=)
RU (1) RU2006134631A (https=)
WO (1) WO2005084306A2 (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ599345A (en) 2005-02-18 2013-07-26 Novartis Vaccines & Diagnostic Immunogens from uropathogenic Escherichia Coli
AU2006214064B2 (en) 2005-02-18 2012-04-26 J. Craig Venter Institute, Inc. Proteins and nucleic acids from meningitis/sepsis-associated escherichia coli
WO2008020330A2 (en) 2006-08-16 2008-02-21 Novartis Ag Immunogens from uropathogenic escherichia coli
CN102105786B (zh) * 2008-07-25 2014-10-29 赛乐思迪斯有限公司 诊断方法
NZ591768A (en) 2008-09-18 2012-11-30 Novartis Ag Vaccine adjuvant combinations
ITMI20090946A1 (it) 2009-05-28 2010-11-29 Novartis Ag Espressione di proteine ricombinanti
CN102740882A (zh) 2009-08-27 2012-10-17 诺华有限公司 含有铝、寡核苷酸和聚阳离子的佐剂
ES2443952T3 (es) 2009-09-02 2014-02-21 Novartis Ag Composiciones inmunógenas que incluyen moduladores de la actividad de TLR
KR20130121699A (ko) 2010-05-28 2013-11-06 테트리스 온라인, 인코포레이티드 상호작용 혼성 비동기 컴퓨터 게임 기반구조
ES2458355T3 (es) 2010-09-01 2014-05-05 Novartis Ag Adsorción de inmunopotenciadores sobre sales metálicas insolubles
US9618508B2 (en) 2010-12-14 2017-04-11 Glaxosmithkline Biologicals Sa Flow cytometry analysis of materials adsorbed to metal salts
WO2012117377A1 (en) 2011-03-02 2012-09-07 Novartis Ag Combination vaccines with lower doses of antigen and/or adjuvant
MX346678B (es) 2012-03-07 2017-03-29 Novartis Ag Sales de arginina utiles inmunologicamente.
JP2015510872A (ja) 2012-03-07 2015-04-13 ノバルティス アーゲー Streptococcuspneumoniae抗原の増強された製剤
MX372965B (es) 2012-03-08 2020-04-01 Glaxosmithkline Biologicals Sa Formulaciones adyuvadas de vacunas de difteria, tetanos y tos ferina (dtp) de refuerzo.
JP6990522B2 (ja) 2017-04-11 2022-02-03 シスメックス株式会社 免疫細胞の免疫刺激応答性を測定する方法、免疫細胞における免疫シナプスの形成能を判定する方法及び細胞分析装置

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6822071B1 (en) * 1998-11-12 2004-11-23 The Regents Of The University Of California Polypeptides from Chlamydia pneumoniae and their use in the diagnosis, prevention and treatment of disease
WO2002002606A2 (en) * 2000-07-03 2002-01-10 Chiron S.P.A. Immunisation against chlamydia pneumoniae

Similar Documents

Publication Publication Date Title
JP2007526318A5 (https=)
CA2759583C (en) A tuberculosis tb vaccine to prevent reactivation
JP2008534594A5 (https=)
JP2008543890A (ja) 改良された結核ワクチン
EP2298342A2 (en) Peptides protective against s. pneumoniae and compositions, methods and uses relating thereto
RU2006134631A (ru) Иммуногенные композиции против chlamidia pneumoniae
RU2016133598A (ru) Композиция микобактериального антигена
EP2269625A2 (en) Protective proteins of S. agalactiae, combinations thereof and methods of using the same
KR20120103882A (ko) 돼지열병바이러스의 탐지용 항원, 이를 이용한 항체 검출 방법, 및 이를 포함하는 탐지키트
JP2010535504A5 (https=)
KR101881947B1 (ko) 기생충 질병에 대한 백신 또는 진단용으로 사용되는 l3 및/또는 l5 공급원의 용도
WO2004020609A3 (en) Streptococcus pneumoniae antigens for diagnosis, treatment and prevention of active infection
Lin et al. Molecular characterization of three major outer membrane proteins, TSA56, TSA47 and TSA22, in Orientia tsutsugamushi
Hoff et al. Molecular cloning and immunological characterisation of potential allergens from the mould Fusarium culmorum
Zhang et al. Development of an indirect ELISA with artificially synthesized N protein of PPR virus
JP2009525741A5 (ja) HERV−W干渉群に属するウィルスの包膜とhASCT受容体との間の相互作用に必要なペプチド領域からなるペプチド
CN101977927A (zh) 针对肺炎链球菌保护的肽以及与其有关的组合物、方法和用途
JP4730764B2 (ja) スギ花粉由来の新規アレルゲン
ITRM20000494A1 (it) Varianti di allergeni ns-ltps, loro usi e composizioni che le comprendono.
WO2015039271A1 (zh) 蛋白a1g_01780在抗立氏立克次体的免疫保护中的应用
CN101248084A (zh) 包含潜伏感染阶段期间所表达的抗原的结核疫苗
KR101954663B1 (ko) 뎅기열 바이러스 ns1에 특이적으로 결합하는 어피바디 이종이량체 및 그의 용도
KR101954685B1 (ko) 뎅기열 바이러스 ns1에 특이적으로 결합하는 어피바디 동종이량체 및 그의 용도
JP2025531113A (ja) ヘリコバクター・ピロリ感染症ワクチン
O'Neil et al. Identification and characterisation of cat allergens